Patent details

Basic Information

Publication number:

EP4039260

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP221536212

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CD62LLOW CD4+ T-CELLS FOR TREATING OR PREVENTING CANCER

French Title of Invention:

CELLULES T CD62LLOW CD4+ POUR TRAITER OU PRÉVENIR LE CANCER

German Title of Invention:

CD62LLOW CD4+ T-ZELLEN ZUR BEHANDLUNG ODER VORBEUGUNG VON KREBS

SPC Number:

Dates

Filing date:

06/02/2018

Grant date:

17/04/2024

EP Publication Date:

10/08/2022

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/04/2024

EP B1 Publication Date:

17/04/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/02/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/04/2024

 

 

Name:

Saitama Medical University

Address:

38, Morohongo Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan (JP)

Inventor

Name:

KAGAMU, Hiroshi

Address:

Japan (JP)

Priority

1

Priority Number:

2017020685

Priority Date:

07/02/2017

Priority Country:

Japan (JP)

2

Priority Number:

2017110069

Priority Date:

02/06/2017

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 35/17; G01N 33/574;

Publication

European Patent Bulletin

Issue number:

202416

Publication date:

17/04/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages